Demant A/S

Demant A/S ROCE

The Return on Capital Employed (ROCE) of Demant A/S (DEMANT.CO) as of Oct 7, 2026 is 40.97 %. In the previous year, Return on Capital Employed (ROCE) was 48.87 % — a change of -16.16% (lower).

ROCE

40.97 %

YoY

-16.16%

Last updated:

In 2025, Demant A/S's return on capital employed (ROCE) was 40.97 %, a -16.16% increase from the 48.87 % ROCE in the previous year.

The Demant A/S ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
35.87 DKK
Jan 1, 2019
28.14 DKK
Jan 1, 2020
18.48 DKK
Jan 1, 2021
43.17 DKK
Jan 1, 2022
37.46 DKK
Jan 1, 2023
44.42 DKK
Jan 1, 2024
48.87 DKK
Jan 1, 2025
40.97 DKK
The Demant A/S ROCE history
YEARROCEYoY
40.97 %-16.16%
48.87 %+10.02%
44.42 %+18.59%
37.46 %-13.23%
43.17 %+133.57%
18.48 %-34.32%
28.14 %-21.56%
35.87 %+14.04%
31.45 %+12.83%
27.88 %-3.51%
28.89 %-8.38%
31.54 %—
Access this data via the Eulerpool API

Demant A/S Stock analysis

What does Demant A/S do? Demant A/S is a Danish company that operates in the field of hearing technology. It was founded in 1904 and is headquartered in Smørum, Denmark. The company has several subsidiaries in various countries, including the USA, Germany, France, and China. The history of Demant began with the founding of the company Oticon by Hans Demant in Copenhagen in 1904. Oticon was the first company to manufacture and sell hearing aids. Since then, the company has evolved into a leading provider of hearing aids, cochlear implants, and assistive listening devices. Demant's business model is based on the development and marketing of hearing technology products. The company is divided into several business areas, including hearing aids, cochlear implants, and diagnostics and consumables. In the field of hearing aids, Demant offers a wide range of products tailored to the needs of different customer groups. These range from basic hearing aids to high-end products with artificial intelligence. Demant's cochlear implant system is a groundbreaking technology that enables deaf or hard-of-hearing individuals to hear. It consists of an implanted device and an external speech processor. Demant's diagnostics and consumables business includes a variety of products used by medical professionals for the diagnosis and treatment of hearing disorders. These include earplugs, audiometry devices, tympanometry devices, and others. Demant is also active in many other areas, including research, development, and production of hearing technology products. The company has a strong global network of partners, distributors, and customers that further strengthens its position as a leading provider of hearing technology products. Overall, Demant has developed a deep understanding of the needs and requirements of people with hearing problems through its commitment to excellence and innovation. With its wide range of products, global network, and deep commitment to customer satisfaction, Demant has become a trusted name in hearing technology. Demant A/S is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Demant A/S's Return on Capital Employed (ROCE)

Demant A/S's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Demant A/S's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Demant A/S's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Demant A/S’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Demant A/S stock

Return on Capital Employed (ROCE) of Demant A/S is 40.97 % in 2025.

Return on Capital Employed (ROCE) of Demant A/S changed from 48.87 % to 40.97 %, representing a -16.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Demant A/S since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Demant A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Demant A/S

All Key Metrics — Demant A/S